Sixth Symposium on Inhaled Therapies for Mycobacterial Pulmonary Diseases
The Sixth Symposium on Inhaled Therapies for Mycobacterial Pulmonary Diseases will be held May 30-31, 2025 at Colorado State University. A detailed agenda can be found below.
Organizing Committee
- Anthony Hickey – Research Triangle Institute
- Francesca Buttini and Paolo Colombo – University of Parma, Italy
- Larry Schlesinger – Texas Biomed
- Rany Condos – New York University
- Miriam Braunstein and Mercedes Gonzalez-Juarrero – Colorado State University
Friday May 30, 2025
| Time | Title & Speaker |
|---|---|
| 2-2:10 p.m. | Welcome. Mercedes Gonzalez-Juarrero-Colorado State University |
| 2:10-3:10 p.m. | Session 1: Evolution and considerations for inhaled therapies and mycobacterial disease. Moderator: Miriam Braunstein-Colorado State University and Francesca Buttini- University of Parma Evolution of inhaled therapy for mycobacterial diseases. Anthony Hickey-RTI International Recent advances in mycobacterial lung disease; consideration for inhaled therapies. |
| 3:10-3:45 p..m. | Coffee break and Meet & Greet |
| 3:45-4:45 p.m. | Session 2: Clinical trials and development programs for inhaled therapies for mycobacterial disease. Moderated by Miriam Braunstein-Colorado State University and Francesca Buttini-University of Parma Development program for inhaled clofazimine for NTM infection. Inhaled GM-CSF for treatment of refractory NTM infection. |
| 4:45-5:15 p.m. | Lightning talks by trainees |
| 5:15-7 p.m. | Reception with heavy Hors d’oeuvres |
Saturday May 31, 2025
| Time | Title & Speaker |
|---|---|
| 8-9 a.m. | Breakfast |
| 9-10:30 a.m. | Session 3: Formulation and delivery of inhaled drugs. Moderator: Paolo Colombo-University of Parma Mix of invited and short talks selected from abstracts: Development of inhaled synergistic antibiotic combinations for treatment of mycobacterial lung disease Engineered Amikacin Dry Powder: High-Dose Administration via Orbital Inhaler and Simulation of Lung Deposition |
| 10:30 a.m.-12 p.m. | Poster presentations, networking & coffee |
| 12-1:30 p.m. | Session 4: PK and PD studies of inhaled drugs for mycobacterial disease Moderator: Anthony Hickey-RTI International Mix of invited and short talks selected from abstracts: Exposure-response assessments guiding development of novel inhaled agents against mycobacteria. PK PD considerations for designing inhaled antimicrobial therapy. |
| 1:30-2:30 p.m. | Lunch |
| 2:30-4 p.m. | Session 5: Preclinical PD of inhaled drugs for mycobacterial disease Moderator: Rany Candos-New York University Mix of invited and short talks selected from abstracts: Inhaled antimycobacterial drugs in combinations. |
| 4-4:15 p.m. | Break |
| 4:15-5:45 p.m. | Session 6: Bacteriophage therapy Moderator: Larry Schlesinger-Texas Biomed Mix of invited and short selected from abstracts: Bacteriophages for nontuberculous mycobacteria. Bacteriophage treatment of Mycobacterium tuberculosis. |
| 5:45-6:15 p.m. | Meeting summary and wrap-up panel discussion. Led by Lucila Garcia-Contreras-University of Oklahoma Health Sciences Center and Francesca Buttini-University of Parma |
Sponsors
We thank our sponsors for their generous support. Select their logo to learn more about each sponsor.
For information on how to become a sponsor, please contact us.
